At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Measure average procedure fluoroscopy time using LumiGuide and conventional fluoroscopy guidance (radiation)
- How long the study runs
- Study runs about 23 months (dates as stated)
- About the drug or intervention
- Measure average procedure fluoroscopy time using LumiGuide and conventional fluoroscopy guidance — radiation: Fenestrated Endovascular Aortic Repair (FEVAR) procedure done with either LumiGuide or conventional fluoroscopy guidance
- Patient visit burden
- Not specified by the sponsor
In plain English
This study, run by Philips Clinical & Medical Affairs Global, is for people having a planned procedure called fenestrated endovascular aortic repair (FEVAR) to treat an aortic aneurysm. The study is called the Radiation Free Study. The aim appears to be linked to the procedure itself, but further details are not stated — ask the trial team.
Who can take part
- You are due to have a first FEVAR procedure (this may include people who have had a previous aortic repair below the kidneys, either with a stent or by open surgery) that includes arteries supplying the organs in the repair.
- You can give informed consent and are aged 18 or over, or are of legal age to consent where you live.
- You are expected to live for at least 2 more years.
- The arteries to be treated are the celiac trunk, the superior mesenteric artery, and the renal (kidney) arteries.
Who may not be able to
- Your repair uses branched devices or iliac branched devices.
- You are having a repeat or staged procedure after a first FEVAR.
- You are being treated for more than 4 target vessels (not counting the contralateral gate).
- You are being treated as an emergency (within 24 hours).
- You have a connective tissue disorder, such as Marfan's or Ehlers Danlos syndrome.
- You are allergic to contrast (the dye used in scans).
- You are taking part in another drug or device trial that could affect this study, unless pre-approved by Philips.
- You are in a vulnerable group, such as having a weakened immune system, lacking capacity to consent, being in an emergency situation, or being pregnant or breastfeeding.
- You are unwilling or unable to follow the study plan or understand verbal or written consent.
What taking part involves
- • Not stated — ask your trial team.
- • You would be having a FEVAR procedure as part of your planned care.
Time commitment: Number of visits and study duration are not stated — ask the trial team; taking part involves having the FEVAR procedure and being treated under the study plan.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 182
- Started
- 2025-07-03
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for aortic aneurysm
- • NA - 182 participants
- • This is a prospective, randomized, unblinded, multi-center study
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with aortic aneurysm
Where?
- • London - Guys & St Thomas
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable. Primary objective is to demonstrate that the average procedure fluoroscopy time using LumiGuide is lower compared to conventional fluoroscopy guidance in Fenestrated Endovascular Aortic Repair (FEVAR)
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Subject is able to give agreement to take part and is 18 years of age or older, or of legal age to give agreement to take part...
- ✓Subject has a expected to live at least 2 $2
- ✓Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery and kidney Arteries
Who cannot take part
- ✗Subjects undergoing an endovascular procedure that include branches or iliac branched devices (IBD) in the repair
- ✗Subject treated for re-intervention / staged procedure post-primary FEVAR procedure
- ✗Subjects intended to be treated for more than 4 target vessels (not counting the contralateral gate)
- ✗Subject treated for an emergent (\<24hrs after emergence) procedure
- ✗Subject with connective tissue disorder eg, Marfan's or Ehlers Danlos Syndrome
See the full criteria
Where Is This Study? (1 UK site)
Guys & St Thomas
London, United Kingdom
How to Get in Touch
Bart Wessels
Sponsor contactCONTACT